BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16732332)

  • 41. A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling.
    Kneip C; Schmidt B; Fleischhacker M; Seegebarth A; Lewin J; Flemming N; Seemann S; Schlegel T; Witt C; Liebenberg V; Dietrich D
    Biotechniques; 2009 Sep; 47(3):737-44. PubMed ID: 19852759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis.
    Youssef EM; Lotan D; Issa JP; Wakasa K; Fan YH; Mao L; Hassan K; Feng L; Lee JJ; Lippman SM; Hong WK; Lotan R
    Clin Cancer Res; 2004 Mar; 10(5):1733-42. PubMed ID: 15014026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
    Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A
    Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage.
    Smith IM; Mydlarz WK; Mithani SK; Califano JA
    Int J Cancer; 2007 Oct; 121(8):1724-8. PubMed ID: 17582607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.
    Calmon MF; Rodrigues RV; Kaneto CM; Moura RP; Silva SD; Mota LD; Pinheiro DG; Torres C; de Carvalho AF; Cury PM; Nunes FD; Nishimoto IN; Soares FA; da Silva AM; Kowalski LP; Brentani H; Zanelli CF; Silva WA; Rahal P; Tajara EH; Carraro DM; Camargo AA; Valentini SR
    Neoplasia; 2009 Dec; 11(12):1329-39. PubMed ID: 20019841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.
    Bertonha FB; Barros Filho Mde C; Kuasne H; Dos Reis PP; da Costa Prando E; Muñoz JJ; Roffé M; Hajj GN; Kowalski LP; Rainho CA; Rogatto SR
    Mol Oncol; 2015 Feb; 9(2):450-62. PubMed ID: 25454821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.
    Bennett KL; Karpenko M; Lin MT; Claus R; Arab K; Dyckhoff G; Plinkert P; Herpel E; Smiraglia D; Plass C
    Cancer Res; 2008 Jun; 68(12):4494-9. PubMed ID: 18559491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display.
    Carles A; Millon R; Cromer A; Ganguli G; Lemaire F; Young J; Wasylyk C; Muller D; Schultz I; Rabouel Y; Dembélé D; Zhao C; Marchal P; Ducray C; Bracco L; Abecassis J; Poch O; Wasylyk B
    Oncogene; 2006 Mar; 25(12):1821-31. PubMed ID: 16261155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis.
    Chalitchagorn K; Shuangshoti S; Hourpai N; Kongruttanachok N; Tangkijvanich P; Thong-ngam D; Voravud N; Sriuranpong V; Mutirangura A
    Oncogene; 2004 Nov; 23(54):8841-6. PubMed ID: 15480421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation as a biomarker for head and neck cancer.
    Arantes LM; de Carvalho AC; Melendez ME; Carvalho AL; Goloni-Bertollo EM
    Oral Oncol; 2014 Jun; 50(6):587-92. PubMed ID: 24656975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Aberrant promoter hypermethylation of tazarotine-induced gene 1 (TIG1) in head and neck cancer].
    Tokumaru Y; Yahata Y; Fujii M
    Nihon Jibiinkoka Gakkai Kaiho; 2005 Dec; 108(12):1152-7. PubMed ID: 16440812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
    Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
    Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas.
    Bennett KL; Lee W; Lamarre E; Zhang X; Seth R; Scharpf J; Hunt J; Eng C
    Genes Chromosomes Cancer; 2010 Apr; 49(4):319-26. PubMed ID: 20029986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.
    Lee KD; Lee HS; Jeon CH
    Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of microsatellite amplifications at chromosomal locus 3q26 as surrogate marker for premalignant changes in mucosa surrounding head and neck squamous cell carcinoma.
    Brieger J; Kastner J; Gosepath J; Mann WJ
    Cancer Genet Cytogenet; 2006 May; 167(1):26-31. PubMed ID: 16682282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC).
    Smiraglia DJ; Smith LT; Lang JC; Rush LJ; Dai Z; Schuller DE; Plass C
    J Med Genet; 2003 Jan; 40(1):25-33. PubMed ID: 12525538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis.
    Bennett KL; Romigh T; Eng C
    Cancer Res; 2009 Dec; 69(24):9301-5. PubMed ID: 19934318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laminin-gamma2 overexpression in head-and-neck squamous cell carcinoma.
    Patel V; Aldridge K; Ensley JF; Odell E; Boyd A; Jones J; Gutkind JS; Yeudall WA
    Int J Cancer; 2002 Jun; 99(4):583-8. PubMed ID: 11992550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utility of MS-MLPA in DNA methylation profiling in primary laryngeal squamous cell carcinoma.
    López F; Sampedro T; Llorente JL; Domínguez F; Hermsen M; Suárez C; Alvarez-Marcos C
    Oral Oncol; 2014 Apr; 50(4):291-7. PubMed ID: 24444674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer.
    Worsham MJ; Chen KM; Stephen JK; Havard S; Benninger MS
    Otolaryngol Head Neck Surg; 2010 Jul; 143(1):116-21, 121.e1-19. PubMed ID: 20620629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.